A Wehmeier
Overview
Explore the profile of A Wehmeier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
172
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gratwohl A, Pfirrmann M, Zander A, Kroger N, Beelen D, Novotny J, et al.
Leukemia
. 2015 Oct;
30(3):562-9.
PMID: 26464170
Tyrosine kinase inhibitors represent today's treatment of choice in chronic myeloid leukemia (CML). Allogeneic hematopoietic stem cell transplantation (HSCT) is regarded as salvage therapy. This prospective randomized CML-study IIIA recruited...
2.
Weber G, Messerschmidt J, Pieck A, Junker A, Wehmeier A, Jaehde U
Anal Bioanal Chem
. 2004 Jul;
380(1):54-8.
PMID: 15278335
Oxaliplatin, a novel diaminocyclohexane-platinum complex, is used for the treatment of metastatic colorectal cancer. The amount of DNA-adduct formation of this drug in white blood cells of patients is determined...
3.
Misgeld E, Wehmeier A, Kromeke O, Gattermann N
Ann Hematol
. 2003 May;
82(7):440-3.
PMID: 12761650
Primary non-Hodgkin's lymphoma of bone (PLB) is a rare entity. We present three new cases and a review of the literature. If PLB is suspected radiologically, the diagnosis must be...
4.
Junker A, Pieck A, Wehmeier A, Jaehde U
Int J Clin Pharmacol Ther
. 2002 Dec;
40(12):569-70.
PMID: 12503817
No abstract available.
5.
Misgeld E, Gattermann N, Wehmeier A, Weiland C, Peters U, Kohne E
Ann Hematol
. 2001 Jul;
80(6):365-7.
PMID: 11475152
The rare hemoglobinopathies with abnormal oxygen binding are usually characterized by erythropoietin-mediated erythrocytosis. Bare et al. first described a hemoglobinopathy with mild erythrocytosis in a 22-year-old Caucasian woman in 1976....
6.
Wehmeier A, Eis-Hubinger A, Maas Enriquez M, Beckmann H
Vox Sang
. 2000 Oct;
79(2):118.
PMID: 11054052
No abstract available.
7.
Michiels J, Kutti J, Stark P, Bazzan M, Gugliotta L, Marchioli R, et al.
Neth J Med
. 1999 Mar;
54(2):46-62.
PMID: 10079679
According to strict clinical, hematological and morphological criteria, the Philadelphia (Ph) chromosome negative chronic myeloproliferative disorders essential thrombocythemia (ET), polycythemia vera (PV), and agnogenic myeloid (megakaryocytic/granulocytic) metaplasia (AMM) or idiopathic...
8.
Meckenstock G, Aul C, Hildebrandt B, Heyll A, Germing U, Wehmeier A, et al.
Leuk Lymphoma
. 1998 Jun;
29(5-6):523-31.
PMID: 9643566
Dyshematopoiesis was found in 44 (42.3%) of 104 cases of de novo acute myeloid leukemia (AML). Dyshematopoietic AML (dys-AML) and AML without hematopoietic dysplasia (non-dys-AML) were compared with regard to...
9.
Sudhoff T, Heins M, Sohngen D, Lenz V, Wehmeier A, Aul C, et al.
Eur J Haematol
. 1998 Mar;
60(2):106-11.
PMID: 9508351
Veno-occlusive disease (VOD) of the liver is a frequent and life-threatening complication of BMT. Recently, successful treatment by t-PA has been reported but has been compromised by fatal bleeding events....
10.
Heyll A, Sohngen D, Kobbe G, Schneider P, Bauser U, Thiele K, et al.
Leukemia
. 1998 Jan;
11 Suppl 5:S32-4.
PMID: 9436936
Following conventional chemotherapy, eight myeloma patients presenting with advanced tumor stages were treated with an intensified high-dose regimen and autologous peripheral blood stem cell transplantation. High-dose chemotherapy consisted of idarubicin...